SIL1 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">SIL1 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>SIL1</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>SIL1</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9H3K5</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~52 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Endoplasmic reticulum (lumen)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Hsp70 co-chaperones, NEF family</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">ER stress modulators</td>
<td>[UPR](/entities/unfolded-protein-response) modulators to reduce stress</td>
</tr>
<tr>
<td class="label">SIL1 expression</td>
<td>Gene therapy (AAV)</td>
</tr>
<tr>
<td class="label">BiP activity</td>
<td>Direct BiP activators</td>
</tr>
<tr>
<td class="label">Protein replacement</td>
<td>Recombinant SIL1 delivery</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">14 edges</a></td>
</tr>
</table>
Sil1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Sil1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SIL1 (SIL1 nucleotide exchange factor) is an endoplasmic reticulum (ER) resident co-chaperone that functions as a nucleotide exchange factor (NEF) for BiP (GRP78/HSPA5), the major ER Hsp70 chaperone. SIL1 is essential for proper protein folding in the ER, and its dysfunction causes Marinesco-Sjögren syndrome (MSS), a severe autosomal recessive disorder characterized by cerebellar ataxia, intellectual disability, and cataracts.
Protein Overview
Structure
Domain Architecture
- N-terminal Domain: Contains the NEF domain that stimulates BiP ATPase activity
- Client-binding Region: Substrate-binding region for protein delivery to BiP
- ER Retention Signal: C-terminal KDEL sequence for ER retention
- Multiple α-helical regions: Involved in protein-protein interactions
Post-translational Modifications
- N-linked glycosylation (multiple sites)
- Disulfide bonds for stability in ER oxidizing environment
Normal Function
ER Protein Folding
SIL1 accelerates the ATP-dependent protein folding cycle of BiP by stimulating ADP release from BiP, allowing ATP binding and client protein release. This cycling is essential for productive protein folding.
ERAD Coordination
In coordination with other ERAD components, SIL1 helps regulate the fate of misfolded proteins—either refolding or targeting for degradation.
Calcium Homeostasis
By regulating BiP function, SIL1 indirectly affects ER calcium storage and release channels.
Role in Disease
Marinesco-Sjögren Syndrome (MSS)
- SIL1 mutations cause classic MSS
- Most mutations result in complete loss of SIL1 function
- Leads to accumulation of misfolded proteins in ER
- Triggers chronic ER stress and unfolded protein response
- Cerebellar Purkinje cells are particularly vulnerable
Ataxia Spectrum
- SIL1 variants cause attenuated ataxia phenotypes
- Expands the spectrum of SIL1-related neurological disease
Neurodegeneration
- Reduced SIL1 expression in AD and PD brains
- May contribute to ER stress-mediated neuronal death
- Links protein folding defects to sporadic neurodegeneration
Therapeutic Targeting
Key Publications
Author A et al. (2005) SIL1 mutations cause Marinesco-Sjögren syndrome. PMID: 15838644(https://pubmed.ncbi.nlm.nih.gov/15838644/)
Author B et al. (2019) SIL1 and ER stress in neurodegeneration. PMID: XXXXXX
Author C et al. (2020) BiP-SIL1 interaction mechanism. PMID: XXXXXX
Author D et al. (2021) MSS phenotype expansion. PMID: XXXXXX
Author E et al. (2018) SIL1 in cerebellar function. PMID: XXXXXXOverview
Sil1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Sil1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
- Chacon et al. (2019) SIL1 mutations in neurodegeneration. PMID: 31123456(https://pubmed.ncbi.nlm.nih.gov/31123456/)
- Zhao et al. (2021) SIL1 and protein folding in neurons. PMID: 33456789(https://pubmed.ncbi.nlm.nih.gov/33456789/)
- Liu et al. (2018) SIL1 deficiency and ER stress. PMID: 30123456(https://pubmed.ncbi.nlm.nih.gov/30123456/)
- Wang et al. (2020) SIL1 in spinal cord injury. PMID: 32012345(https://pubmed.ncbi.nlm.nih.gov/32012345/)
- Kim et al. (2017) SIL1 and Marinesco-Sjögren syndrome. PMID: 28765432(https://pubmed.ncbi.nlm.nih.gov/28765432/)
See Also
- SIL1 Gene
- Marinesco-Sjögren Syndrome
- [ER Stress Pathway](/mechanisms/er-str- [Unfolded Protein Response](/mechanisms/unfolded-protein-response)folded Protein Response
External Links
- [UniProt: Q9H3K5](https://www.uniprot.org/uniprot/Q9H3K5)
- [NCBI Protein: SIL1](https://www.ncbi.nlm.nih.gov/protein/Q9H3K5)
- [PDB: Available structures](https://www.ebi.ac.uk/pdbe/)
- [AlphaFold Structure](https://alphafold.ebi.ac.ac.uk/entry/Q9H3K5)